44 results
424B5
HUMA
Humacyte Inc
1 Mar 24
Prospectus supplement for primary offering
4:05pm
) on the gain derived from the sale, which gain may be offset by U.S.-source capital losses for the year; or
we are or have been a United States real property
424B5
HUMA
Humacyte Inc
29 Feb 24
Prospectus supplement for primary offering
4:11pm
an applicable income tax treaty) on the gain derived from the sale, which gain may be offset by U.S.-source capital losses for the year; or
we are or have
8-K
EX-99.1
dal8ljy5k ig4ht52q
9 Nov 23
Humacyte Third Quarter 2023 Financial Results and Business Update
4:07pm
8-K
EX-99.1
mxqjh1uq38 31gww3
10 Nov 22
Humacyte Third Quarter 2022 Financial Results and Business Update
7:04am
424B3
o2m0bmd6cxosih
12 Aug 22
Prospectus supplement
9:11am
8-K
EX-99.1
kwl1yhmb1xpw237
12 Aug 22
Humacyte Second Quarter 2022 Financial Results and Business Update
7:04am
424B3
fed2ag0com4fzyhm566
13 May 22
Prospectus supplement
9:14am
8-K
EX-99.1
e8wodtj
13 May 22
Humacyte First Quarter 2022 Financial Results and Business Update
7:03am
DEF 14A
llbci cdrv5a1qxvtq
29 Apr 22
Definitive proxy
6:41am
424B7
924kt8l0 4z1e4t
4 Apr 22
Prospectus with selling stockholder info
5:22pm